Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study
<p>Abstract</p> <p>Background</p> <p>Accurate prediction of infection, including maternal chorioamnionitis and early-onset neonatal infection, remains a critical challenge in cases of preterm rupture of membranes and may influence obstetrical management. The aim of our...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | BMC Pregnancy and Childbirth |
Online Access: | http://www.biomedcentral.com/1471-2393/11/26 |
id |
doaj-572f74d1accf4b299a51ffae6a6746e4 |
---|---|
record_format |
Article |
spelling |
doaj-572f74d1accf4b299a51ffae6a6746e42020-11-24T21:09:27ZengBMCBMC Pregnancy and Childbirth1471-23932011-04-011112610.1186/1471-2393-11-26Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective studySchmitz ThomasMaillard FrançoiseGoffinet FrançoisPopowski ThomasLeroy SandrineKayem Gilles<p>Abstract</p> <p>Background</p> <p>Accurate prediction of infection, including maternal chorioamnionitis and early-onset neonatal infection, remains a critical challenge in cases of preterm rupture of membranes and may influence obstetrical management. The aim of our study was to investigate the predictive value for early-onset neonatal infection and maternal histological and clinical chorioamnionitis of maternal biological markers in routine use at or after 34 weeks of gestation in women with premature rupture of membranes.</p> <p>Methods</p> <p>We conducted a two-center prospective study of all women admitted for premature rupture of membranes at or after 34 weeks of gestation. The association of C-reactive protein, white blood cell count, vaginal sample bacteriological results, and a prediction model at admission, for early-onset neonatal infection and maternal chorioamnionitis were analyzed by comparing areas under the receiver operating characteristic curves and specificity.</p> <p>Results</p> <p>The study included 399 women. In all, 4.3% of the newborns had an early-onset neonatal infection and 5.3% of the women had clinical chorioamnionitis. Histological chorioamnionitis was detected on 10.8% of 297 placentas tested. White blood cell counts and C-reactive protein concentrations were significantly associated with early-onset neonatal infection and included in a prediction model. The area under the receiver operating characteristic curve of this model was 0.82 (95% CI [0.72, 0.92]) and of C-reactive protein, 0.80 (95% CI [0.68, 0.92]) (p = 1.0). Specificity was significantly higher for C-reactive protein than for the prediction model (48% and 43% respectively, p < 0.05). C-reactive protein was associated with clinical and histological chorioamnionitis, with areas under the receiver operating characteristic curve of 0.61 (95% CI [0.48, 0.74]) and 0.62 (95% CI [0.47, 0.74]), respectively.</p> <p>Conclusions</p> <p>The concentration of C-reactive protein at admission for premature rupture of membranes is the most accurate infectious marker for prediction of early-onset neonatal infection in routine use with a sensitivity > 90%. A useful next step would be a randomized prospective study of management strategy comparing CRP at admission with active management to assess whether this more individualized care is a safe alternative strategy in women with premature rupture of membranes at or after 34 weeks.</p> http://www.biomedcentral.com/1471-2393/11/26 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Schmitz Thomas Maillard Françoise Goffinet François Popowski Thomas Leroy Sandrine Kayem Gilles |
spellingShingle |
Schmitz Thomas Maillard Françoise Goffinet François Popowski Thomas Leroy Sandrine Kayem Gilles Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study BMC Pregnancy and Childbirth |
author_facet |
Schmitz Thomas Maillard Françoise Goffinet François Popowski Thomas Leroy Sandrine Kayem Gilles |
author_sort |
Schmitz Thomas |
title |
Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study |
title_short |
Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study |
title_full |
Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study |
title_fullStr |
Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study |
title_full_unstemmed |
Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study |
title_sort |
maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study |
publisher |
BMC |
series |
BMC Pregnancy and Childbirth |
issn |
1471-2393 |
publishDate |
2011-04-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Accurate prediction of infection, including maternal chorioamnionitis and early-onset neonatal infection, remains a critical challenge in cases of preterm rupture of membranes and may influence obstetrical management. The aim of our study was to investigate the predictive value for early-onset neonatal infection and maternal histological and clinical chorioamnionitis of maternal biological markers in routine use at or after 34 weeks of gestation in women with premature rupture of membranes.</p> <p>Methods</p> <p>We conducted a two-center prospective study of all women admitted for premature rupture of membranes at or after 34 weeks of gestation. The association of C-reactive protein, white blood cell count, vaginal sample bacteriological results, and a prediction model at admission, for early-onset neonatal infection and maternal chorioamnionitis were analyzed by comparing areas under the receiver operating characteristic curves and specificity.</p> <p>Results</p> <p>The study included 399 women. In all, 4.3% of the newborns had an early-onset neonatal infection and 5.3% of the women had clinical chorioamnionitis. Histological chorioamnionitis was detected on 10.8% of 297 placentas tested. White blood cell counts and C-reactive protein concentrations were significantly associated with early-onset neonatal infection and included in a prediction model. The area under the receiver operating characteristic curve of this model was 0.82 (95% CI [0.72, 0.92]) and of C-reactive protein, 0.80 (95% CI [0.68, 0.92]) (p = 1.0). Specificity was significantly higher for C-reactive protein than for the prediction model (48% and 43% respectively, p < 0.05). C-reactive protein was associated with clinical and histological chorioamnionitis, with areas under the receiver operating characteristic curve of 0.61 (95% CI [0.48, 0.74]) and 0.62 (95% CI [0.47, 0.74]), respectively.</p> <p>Conclusions</p> <p>The concentration of C-reactive protein at admission for premature rupture of membranes is the most accurate infectious marker for prediction of early-onset neonatal infection in routine use with a sensitivity > 90%. A useful next step would be a randomized prospective study of management strategy comparing CRP at admission with active management to assess whether this more individualized care is a safe alternative strategy in women with premature rupture of membranes at or after 34 weeks.</p> |
url |
http://www.biomedcentral.com/1471-2393/11/26 |
work_keys_str_mv |
AT schmitzthomas maternalmarkersfordetectingearlyonsetneonatalinfectionandchorioamnionitisincasesofprematureruptureofmembranesatorafter34weeksofgestationatwocenterprospectivestudy AT maillardfrancoise maternalmarkersfordetectingearlyonsetneonatalinfectionandchorioamnionitisincasesofprematureruptureofmembranesatorafter34weeksofgestationatwocenterprospectivestudy AT goffinetfrancois maternalmarkersfordetectingearlyonsetneonatalinfectionandchorioamnionitisincasesofprematureruptureofmembranesatorafter34weeksofgestationatwocenterprospectivestudy AT popowskithomas maternalmarkersfordetectingearlyonsetneonatalinfectionandchorioamnionitisincasesofprematureruptureofmembranesatorafter34weeksofgestationatwocenterprospectivestudy AT leroysandrine maternalmarkersfordetectingearlyonsetneonatalinfectionandchorioamnionitisincasesofprematureruptureofmembranesatorafter34weeksofgestationatwocenterprospectivestudy AT kayemgilles maternalmarkersfordetectingearlyonsetneonatalinfectionandchorioamnionitisincasesofprematureruptureofmembranesatorafter34weeksofgestationatwocenterprospectivestudy |
_version_ |
1716758255552692224 |